These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 7564485

  • 41. Effect and toxicity of endoluminal high-dose-rate (HDR) brachytherapy in centrally located tumors of the upper respiratory tract.
    Harms W, Schraube P, Becker H, Latz D, Herth F, Fritz P, Wannenmacher M.
    Strahlenther Onkol; 2000 Feb; 176(2):60-6. PubMed ID: 10697652
    [Abstract] [Full Text] [Related]

  • 42. Endobronchial brachytherapy in combination with external beam irradiation in obstructing malignant bronchial tumors.
    Prévost A, Berthiot G, Picavet B, Froissart D, Loirette M, Costa B, Cauchois A, Nguyen TD.
    Oncol Rep; 2003 Feb; 10(4):921-5. PubMed ID: 12792746
    [Abstract] [Full Text] [Related]

  • 43. Salvage treatment with sole high-dose-rate endobronchial interventional radiotherapy (brachytherapy) for isolated endobronchial tumor recurrence in non-small-cell lung cancer patients: a 20-year experience.
    Soror T, Kovács G, Fürschke V, Ismail M, Badakhshi H.
    Brachytherapy; 2019 Feb; 18(5):727-732. PubMed ID: 31227399
    [Abstract] [Full Text] [Related]

  • 44. High-dose-rate brachytherapy in symptom palliation due to malignant endobronchial obstruction: a quantitative assessment.
    de Aquino Gorayeb MM, Gregório MG, de Oliveira EQ, Aisen S, Carvalho Hde A.
    Brachytherapy; 2013 Feb; 12(5):471-8. PubMed ID: 23541114
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Endobronchial brachytherapy and optimization of local disease control in medically inoperable non-small cell lung carcinoma: a matched-pair analysis.
    Mantz CA, Dosoretz DE, Rubenstein JH, Blitzer PH, Katin MJ, Garton GR, Nakfoor BM, Siegel AD, Tolep KA, Hannan SE, Dosani R, Feroz A, Maas C, Bhat S, Panjikaran G, Lalla S, Belani K, Ross RH.
    Brachytherapy; 2004 Feb; 3(4):183-90. PubMed ID: 15607149
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Survival benefits of lung cancer patients undergoing laser and brachytherapy.
    Jang TW, Blackman G, George JJ.
    J Korean Med Sci; 2002 Jun; 17(3):341-7. PubMed ID: 12068137
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Second line palliative endobronchial radiotherapy with HDR Ir 192 in recurrent lung carcinoma.
    Zorlu AF, Selek U, Emri S, Gurkaynak M, Akyol FH.
    Yonsei Med J; 2008 Aug 30; 49(4):620-4. PubMed ID: 18729305
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. A systematic overview of radiation therapy effects in non-small cell lung cancer.
    Sirzén F, Kjellén E, Sörenson S, Cavallin-Ståhl E.
    Acta Oncol; 2003 Aug 30; 42(5-6):493-515. PubMed ID: 14596509
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.